Literature DB >> 4203419

Quantitative and qualitative aspects of the plasma protein binding of carbenoxolone, an ulcer-healing drug.

D V Parke, W E Lindup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4203419     DOI: 10.1111/j.1749-6632.1973.tb20482.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Proceedings: Interaction of carbenoxolone sodium with other drigs bound to plasma proteins.

Authors:  S Gottfried; D V Parke; P J Sacra; P C Thornton
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Anatomy and radiology of the areae gastricae.

Authors:  C E Mackintosh; L Kreel
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

3.  Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects.

Authors:  M J Hayes; M Sprackling; M J Langman
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

4.  Drugs for peptic ulcer.

Authors:  C G Clark; J H Wyllie
Journal:  World J Surg       Date:  1977-01       Impact factor: 3.352

5.  The influence of carbenoxolone on steroid-induced ulcer and mucus secretion in the rat.

Authors:  M Berg; A Geisel; H Necheles
Journal:  Am J Dig Dis       Date:  1975-02

Review 6.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Reinvestigation of the effect of carbenoxolone on the induction of heat shock proteins.

Authors:  Daisuke Kawashima; Midori Asai; Kiyoe Katagiri; Rika Takeuchi; Kenzo Ohtsuka
Journal:  Cell Stress Chaperones       Date:  2009-03-31       Impact factor: 3.667

8.  Active sulforhodamine 101 uptake into hippocampal astrocytes.

Authors:  Christian Schnell; Yohannes Hagos; Swen Hülsmann
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.